P251 (Hyoscyamine sulfate extended release 0.375 mg)
Pill imprint P251 has been identified as Hyoscyamine sulfate extended release 0.375 mg.
Hyoscyamine is used in the treatment of irritable bowel syndrome; crohn's disease; anesthesia; urinary incontinence; endoscopy or radiology premedication and belongs to the drug class anticholinergics/antispasmodics. Risk cannot be ruled out during pregnancy. Hyoscyamine 0.375 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for P251 (Hyoscyamine sulfate extended release 0.375 mg)
- 0.375 mg
- 13.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Paddock Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
hypromellose 2208 (15000 mPa.s)
Hyoscyamine sulfate extended release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...